172 related articles for article (PubMed ID: 3317410)
1. Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells.
May WS; Sharkis SJ; Esa AH; Gebbia V; Kraft AS; Pettit GR; Sensenbrenner LL
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8483-7. PubMed ID: 3317410
[TBL] [Abstract][Full Text] [Related]
2. The action of bryostatin on normal human hematopoietic progenitors is mediated by accessory cell release of growth factors.
Sharkis SJ; Jones RJ; Bellis ML; Demetri GD; Griffin JD; Civin C; May WS
Blood; 1990 Aug; 76(4):716-20. PubMed ID: 2200537
[TBL] [Abstract][Full Text] [Related]
3. The in vitro effect of the antineoplastic agent bryostatin 4 on human hematopoietic progenitor cells.
Gebbia V; Di Marco P; Miceli S; Reyes MB; Teresi M; Bonaccorso R; Citarrella P; Rausa L
Haematologica; 1988; 73(5):387-91. PubMed ID: 3143638
[No Abstract] [Full Text] [Related]
4. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
5. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM).
Grant S; Pettit GR; McCrady C
Exp Hematol; 1992 Jan; 20(1):34-42. PubMed ID: 1374343
[TBL] [Abstract][Full Text] [Related]
6. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells.
Grant S; Traylor R; Bhalla K; McCrady C; Pettit GR
Leukemia; 1992 May; 6(5):432-9. PubMed ID: 1593908
[TBL] [Abstract][Full Text] [Related]
7. Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor.
Grant S; Pettit GR; Howe C; McCrady C
Leukemia; 1991 May; 5(5):392-8. PubMed ID: 2033960
[TBL] [Abstract][Full Text] [Related]
8. The antineoplastic bryostatins affect human basophils and mast cells differently.
Patella V; Casolaro V; Ciccarelli A; Pettit GR; Columbo M; Marone G
Blood; 1995 Mar; 85(5):1272-81. PubMed ID: 7532037
[TBL] [Abstract][Full Text] [Related]
9. Effect of pharmacologic manipulation of protein kinase C by phorbol dibutyrate and bryostatin 1 on the clonogenic response of human granulocyte-macrophage progenitors to recombinant GM-CSF.
McCrady CW; Staniswalis J; Pettit GR; Howe C; Grant S
Br J Haematol; 1991 Jan; 77(1):5-15. PubMed ID: 1998597
[TBL] [Abstract][Full Text] [Related]
10. Role of TNF alpha in bryostatin-induced inhibition of human hematopoiesis.
Dräger AM; van der Hem KG; Zevenbergen A; Odding JH; Huijgens PC; Schuurhuis GJ
Leukemia; 1999 Jan; 13(1):62-9. PubMed ID: 10049062
[TBL] [Abstract][Full Text] [Related]
11. Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors.
Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; van der Hem KG; Odding JH; Dräger AM; Ossenkoppele GJ
Br J Cancer; 1999 Mar; 79(9-10):1406-12. PubMed ID: 10188883
[TBL] [Abstract][Full Text] [Related]
12. Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro.
Jones RJ; Sharkis SJ; Miller CB; Rowinsky EK; Burke PJ; May WS
Blood; 1990 Mar; 75(6):1319-23. PubMed ID: 2310830
[TBL] [Abstract][Full Text] [Related]
13. Bryostatin 1 modulates the proliferation and lineage commitment of human myeloid progenitor cells exposed to recombinant interleukin-3 and recombinant granulocyte-macrophage colony-stimulating factor.
Li F; Grant S; Pettit GR; McCrady CW
Blood; 1992 Nov; 80(10):2495-502. PubMed ID: 1421372
[TBL] [Abstract][Full Text] [Related]
14. Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities.
Emerson SG; Yang YC; Clark SC; Long MW
J Clin Invest; 1988 Oct; 82(4):1282-7. PubMed ID: 3049674
[TBL] [Abstract][Full Text] [Related]
15. Bryostatins trigger human polymorphonuclear neutrophil and monocyte oxidative metabolism: association with in vitro antineoplastic activity.
Esa AH; Warren JT; Hess AD; May WS
Res Immunol; 1995; 146(6):351-61. PubMed ID: 8719659
[TBL] [Abstract][Full Text] [Related]
16. Regulation of hematopoiesis-IV: The role of interleukin-3 and bryostatin 1 in the growth of erythropoietic progenitors from normal and anemic W/Wv mice.
Leonard JP; May WS; Ihle JN; Pettit GR; Sharkis SJ
Blood; 1988 Nov; 72(5):1492-6. PubMed ID: 3263149
[TBL] [Abstract][Full Text] [Related]
17. Structure of bryostatin 20: a symbiont-produced chemical defense for larvae of the host bryozoan, Bugula neritina.
Lopanik N; Gustafson KR; Lindquist N
J Nat Prod; 2004 Aug; 67(8):1412-4. PubMed ID: 15332866
[TBL] [Abstract][Full Text] [Related]
18. The clinical development of the bryostatins.
Clamp A; Jayson GC
Anticancer Drugs; 2002 Aug; 13(7):673-83. PubMed ID: 12187323
[TBL] [Abstract][Full Text] [Related]
19. In vivo stimulation of murine haematopoiesis by the antineoplastic agent bryostatin-1.
Gebbia V; Gebbia N; Rausa L; Sharkis SJ; May WS
Pharmacol Res; 1990; 22 Suppl 1():103-4. PubMed ID: 2284223
[No Abstract] [Full Text] [Related]
20. Mechanism of synergy between granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in colony formation from human marrow cells in vitro.
Hara H; Namiki M
Exp Hematol; 1989 Aug; 17(7):816-21. PubMed ID: 2473914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
